Forex / Alpha Vantage News Sentiment

EyePoint Pharmaceuticals updates its strategy as retinal pipeline advances

EyePoint Pharmaceuticals is updating its strategy as its pipeline of long-acting eye therapies for retinal diseases advances. The company specializes in sustained intraocular drug delivery, aiming to reduce treatment burden for patients. Its focus is on developing proprietary implants that release medication over extended periods, targeting conditions like age-related macular degeneration and diabetic eye disease.